We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Com-Cov

News List

‘Mix and match’ COVID-19 vaccine study yields promising results pharmatimes
June 30, 2021
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
Oxford Immunotec’s COVID-19 test to be used in ‘mix and match’ UK vaccine trial pharmatimes
April 28, 2021
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 test kit is set to be used for T cell testing in the UK Com-Cov trial, which is evaluating different combinations of approved COVID-19 vaccines.
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded pharmatimes
April 15, 2021
A UK trial evaluating the safety of mixing different COVID-19 vaccines is set to be expanded to include Moderna and Novavax’s respective jabs.
UK trial will evaluate safety of mixing different COVID-19 vaccines pharmatimes
February 04, 2021
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.